Products Polio vaccine Headquarters India Founded 1989 | Website bibcol.com Owner Government of India | |
 | ||
Key people Sh. Chandra Prakash Goyal
(Managing Director) Stock price 524663 (BOM) ₹ 20.50 -0.55 (-2.61%)6 Mar, 1:35 PM IST - Disclaimer | ||
Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Public Sector Undertaking (PSU) of the Government of India. Established in 1989 in Bulandshahar, Uttar Pradesh, BIBCOL manufactures oral polio vaccines (OPVs) and other immunisers. The company formulates over 125 million doses of OPV and had aggregated revenues of ₹305 million (US$4.5 million) in fiscal 2006.
BIBCOL is under the administrative control of the Department of Biotechnology, Ministry of Science and Technology.
Products
- Diarrhea Management Kit—Diarrhea Management Kit (Zinc Tablet + oral rehydration salts (ORS)) for management of diarrhea among young children.
- Oral Polio Vaccine—The live oral polio vaccine (OPV) is a trivalent vaccine containing suspensions of type 1, 2 and 3 attenuated poliomyelitis viruses (Sabin strains) prepared in primary moneky kidney cell culture.
- Zinc Dispersable Tablet—The dispersible zinc tablet, BIBZinC-20 mg contains 20 mg of elemental zinc as active ingredient and contains sweetener and taste masker (Vanilla flavor) and is scored tablet. The product is in line with the recommendations of the WHO. The product is produced with technology transfer from Nutriset (French company) through the Department of Biotechnology, Ministry of Science and Technology, Government of India. The Nutriset product has been tested in Indian fields and clinical trials have evaluated the efficacy of zinc supplementation and safety.
- IFA Tablets—Iron-deficiency anemia (IDA) is most ignored in developing countries and is the major cause of anemia. The Iron Folic Tablets (IFA Tablets) are a crucial component for treatment of iron deficiency and IDA.
References
Bharat Immunologicals and Biologicals Corporation Wikipedia(Text) CC BY-SA